CoChat

Efficacy and Safety of Meal Replacement in Patients With Type 2 Diabetes

Ye, Wenjing, Xu, Lijuan, Ye, Yanbin, Zeng, Fangfang, Lu, Xin, Li, Yanbing, Liu, Liehua · 2023 · The Journal of Clinical Endocrinology & Metabolism
Cited by 17

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Context: Meal replacement (MR) is beneficial for the management of type 2 diabetes (T2D). However, MR prescription and patient characteristics vary substantially between studies using MR in T2D patients. Objective: This work aimed to evaluate the efficacy and safety of MR in T2D patients by meta-analysis, with a focus on subgroup analysis of variable participant characteristics and MR prescription. Methods: We searched PubMed, CENTRAL, Embase, Web of Science, and the clinical trial registration database up to March 2022. We included randomized controlled trials (RCTs) of 2 weeks or more assessing the effect and safety of MR in T2D patients in comparison with conventional diabetic diets (CDs). Results: A total of 17 RCTs involving 2112 participants were ultimately included. Compared with CDs, MR significantly reduced glycated hemoglobin A1c (HbA1c) (MD −0.46%; P < .001), fasting blood glucose (FBG, −0.62 mmol/L; P < .001), body weight (−2.43 kg; P < .001), and body mass index (BMI, −0.65; P < .001), and improved other cardiometabolic risk factors. In subgroup analyses, total MR showed greater improvement in HbA1c (−0.72% vs −0.32%; P = .01), FBG (−1.45 vs −0.56 mmol/L; P = .02), body weight (−6.57 vs −1.58 kg; P < .001), and BMI (−2.78 vs −0.37; P < .001) than partial MR. MR with caloric restriction showed more reduction in body weight (−3.20 vs −0.75 kg; P < .001) and BMI (−0.84 vs −0.24; P = .003) compared with those without caloric restriction. MR showed similar benefits in studies that included patients using insulin and those that did not. Both partial and total MR were well tolerated. Conclusion: Compared with CDs, the MR-based dietary pattern further improved the glycemic control and adipose indicators in T2D patients. Appropriate calorie restriction and total MR might be more beneficial, while both patients treated with or without insulin treatment could similarly benefit from MR usage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgad273

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 17

Metadata

Authors
Ye, W., Xu, L., Ye, Y., Zeng, F., Lu, X., Li, Y., & Liu, L.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2023-05-16
Volume
108
Issue
11
Pages
3041-3049
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W4376870962
Cited by
17
References
16
FWCI
2.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy and Safety of Meal Replacement in Patients With Type 2 Diabetes. https://app.cochat.ai/papers/10.1210/clinem/dgad273
The paper
Ye, W., Xu, L., Ye, Y., Zeng, F., Lu, X., Li, Y., & Liu, L. (2023). Efficacy and Safety of Meal Replacement in Patients With Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad273

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.